 |
 |

Hemophilia: Quantitative Studies of the Coagulation DefectA Modified Prothrombin-Consumption Test Using Erythrocytin
ARMAND J. QUICK, M.D.;
CLARA V. HUSSEY, M.S.
AMA Arch Intern Med. 1956;97(5):524-531.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
The prothrombin-consumption test described by one of us in 1947 1 was based on the assumption that the amount of prothrombin remaining in serum when blood clotted under standardized conditions was a measure of the thromboplastin that resulted from the interaction of platelets with a plasma constituent which was designated as thromboplastinogen. It was concluded that the poor consumption of prothrombin observed when hemophilic blood clotted was caused by a lack of this plasma factor and that, therefore, the method could be employed for its assay. This assumption was supported by the significant increase in prothrombin consumption obtained after giving a hemophiliac a transfusion of normal blood or plasma. In mild hemophilia, however, the results were not always consistent, and, peculiarly, it was observed that when the platelet-rich plasma of such patients was clotted the prothrombin consumption was lower and more constant than when the test was done on whole
. . . [Full Text PDF of this Article]
Author Affiliations
Milwaukee
From the Department of Biochemistry, Marquette University School of Medicine.
Footnotes
Submitted for publication Oct. 20, 1955.
This work was supported by a grant (H1612 C8) from the National Heart Institute, National Institutes of Health, United States Public Health Center.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|